BACKGROUND:
Improving FIO2
and reducing CO2 rebreathing (V̇ICO2
) are the key means to improve the therapeutic efficacy of noninvasive ventilation (NIV). This study aimed to investigate the impact of interface design on FIO2
and V̇ICO2
during NIV.
METHODS:
A simulated lung model was established to analyze 17 different interfaces. CO2 was injected into the outlet of the simulated lung, and the noninvasive ventilator was connected to the simulated lung to simulate the application of NIV in patients with COPD with hypercapnia. FIO2
and V̇ICO2
were calculated by mathematical integration of synchronously collected data pertaining to real-time pressure, flow, oxygen concentration, and CO2 concentration in the breathing circuit. Comparisons were performed between different types (nasal vs oronasal) and models of interfaces as well as between interfaces with different leak positions. Correlation of FIO2
and V̇ICO2
with inner volume and leakage, respectively, and the correlation between FIO2
and V̇ICO2
were analyzed.
RESULTS:
FIO2
levels were significantly different with a nasal or an oronasal mask (0.45 ± 0.05% vs 0.41 ± 0.08%, respectively; P < .001). FIO2
levels associated with different models of interfaces varied significantly (all P < .001); V̇ICO2
did not differ significantly among the different interfaces (P = .19). Leak position significantly affected FIO2
and V̇ICO2
(all P < .001). Both inner volume and leakage significantly correlated with FIO2
(r = −0.23, P < .001; r = −0.08, P = .02). There was a significant correlation between FIO2
and V̇ICO2
(r = 0.43, P < .01); the general linear equation was y = 0.17 + 0.02x (r = 0.43, R2 = 0.19).
CONCLUSIONS:
The design of the interface had a significant impact on FIO2
and V̇ICO2
during NIV. FIO2
and V̇ICO2
showed a significant positive correlation, although the effect size of correlation was moderate.